Relationship of curative surgery on natural killer cell activity in colorectal cancer

Diseases of the Colon and Rectum

Volumn 39, Issue 4, 1996, Pages 429-434

  Espí, Alejandro ^a   Arenas, Javier ^a   García Granero, Eduardo ^a   Martí, Elena ^a   Lledó, Salvador ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Colorectal cancer; Natural killer activity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MALE; NATURAL KILLER CELL;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE PERIOD;

EID: 0029922812     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02054059     Document Type: Article

References (20)

1. Rosenberg SA, Lotze MT, Muul LM, et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 1985; 313:1485-92.
2. Mule JJ, Yang J, Shu S, Rosenberg SA. The anti-tumour efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells. J Immunol 1986; 136:3899-909.
3. Hawkins MJ, Atkins MB, Dutcher JP, et al. A phase II clinical trial of interleukin 2 and lymphokine-activated killer cells in advanced colorectal carcinoma. J Immunother 1994;15:74-8.
4. Steis RG, Urba WJ, Van der Molen LA, et al. Intraperitoneal lymphokine-activated killer cell and interleukin 2 therapy for malignancies limited to the peritoneal cavity. J Clin Oncol 1990;8:1618-29.
5. Parks KG, Heys SD, Murray JB, et al. Recombinant interleukin-2 treatment in patients with metastatic colorectal cancer: effect on natural cytotoxicity. Cancer Immunol Immunother 1992;35:53-8.
6. Riddle PR, Berenbaum MC. Postoperative depression of the lymphocyte response to phytohemagglutinin. Lancet 1967;1:746-8.
7. Berenbaum MC, Fluck PA, Hurst NP. Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol 1973;54:597-607.
8. Cullen BF, Van Belle G. Lymphocyte transformation and changes in leukocyte count: effects of anesthesia and operation. Anesthesiology 1975;43;563-9.
9. Miller GC, Pritchard DJ, Ritts RE, Ivins JC, Pierre RV. Effect of surgery on the quantity of lymphocyte subpopulations. J Surg Res 1976;21:155-8.
10. Gzerlak I, Olszewski WL, Engeset A. Influence of operative trauma on circulating blood mononuclear cells: analysis using monoclonal antibodies. Eur Surg Res 1984;16:105-12.
11. Hansbrough JF, Bender EM, Zapata-Sirvent R, Anderson J. Altered helper and suppressor lymphocyte populations in surgical patients: a measure of postoperative immunosuppression. Am J Surg 1984;148:303-7.
12. Takii Y, Hashimoto S, Iiai T, Watanabe H, Hatakeyama K, Abo T. Increase in the proportion of granulated CD56+ T cells in patients with malignancy. Clin Exp Immunol 1994;97:522-7.
13. Sedman PC, Ramsden CW, Brennan TG, Giles GR, Guillou PJ. Effects of low dose perioperative interferon on the surgically induced suppression of antitumour immune responses. Br J Surg 1988;75:976-81.
14. Nichols PH, Ramsden CW, Ward U, Sedman PC, Primrose JN. Perioperative immunotherapy with recombinant interleukin 2 in patients undergoing surgery for colo-rectal cancer. Cancer Res 1992;52:5765-9.
15. Nichols PH, Ramsden CW, Ward U, Trejdosiewicz LK, Ambrose NS, Primrose JN. Perioperative modulation of cellular immunity in patients with colorectal cancer. Clin Exp Immunol 1993;94:4-10.
16. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1g. Scand J Clin Lab Invest Suppl 1968;21:77-89.
17. European CML Study Group on the Third European CML Workshop. Human histocompatibility testing by T-cell mediated lympholysis: a European standard CML technique. Tissue Antigens 1980;16:335-45.
18. Wiltrout RH, Herberman RB, Zhang SR, et al. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985;134:4267-75.
19. Blottiere HM, Douillard JY, Koprowski H, Steplewski Z. Humoral and cellular responses of colorectal cancer patients treated with monoclonal antibodies and interferon gamma. Cancer Immunol Immunother 1990;32: 29-37.
20. Atzpodien J, Kirchner H, Korfer A, et al. Expansion of peripheral blood natural killer cells correlates with clinical outcome in cancer patients receiving recombinant subcutaneous interleukin-2 and interferon-alpha 2. Tumour Biol 1993;14:354-9.